Goldman Sachs
IART icon

Goldman Sachs’s Integra LifeSciences IART Stock Holding History

Goldman Sachs’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,200
Closed -$362K – 5771
2024
Q1 		$362K Buy
+10,200
New +$408K ﹤0.01% 4888
2023
Q1 		– Sell
-170,800
Closed -$9.58M – 6061
2022
Q4 		$9.58M Buy
+170,800
New +$8.69M ﹤0.01% 2631
2014
Q2 		– Sell
-73,394
Closed -$1.38M – 7062
2014
Q1 		$1.38M Buy
73,394
+1,223
+2% +$23.6K ﹤0.01% 4346
2013
Q4 		$1.41M Buy
+72,171
New +$1.32M ﹤0.01% 4431

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs's IART Position: Q1 2026 in Review

Goldman Sachs increased its Integra LifeSciences (IART) stake by 31% in Q1 2026, buying an estimated $4.84M and bringing the position to 1,876,750 shares worth $17.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2554.

Goldman Sachs first reported a position in IART in Q2 2013 and has held it in 52 quarters since. The position peaked at $99.3M in Q4 2021. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • Goldman Sachs held 1,876,750 shares of Integra LifeSciences worth $17.7M as of Q1 2026.
  • Goldman Sachs bought 441,023 Integra LifeSciences shares in Q1 2026, an estimated $4.84M.
  • Integra LifeSciences made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #2554 holding.
  • Goldman Sachs first reported a position in Integra LifeSciences in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Integra LifeSciences position peaked at $99.3M in Q4 2021.
  • 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.